- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03690960
Antimicrobial Effect of Modified Antibiotic Nanofibers for Regenerative Endodontics Procedures
Evaluation of the Antimicrobial Effect of Pre-synthesized Novel Antibiotic Electrospun Nanofibers as an Intracanal Delivery Strategy for Regenerative Endodontics A Randomized Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Title: Evaluation of the Antimicrobial Effect of Pre-synthesized Novel Antibiotic Electrospun Nanofibers as an Intracanal Delivery Strategy for Regenerative Endodontics - A Randomized Clinical Trial
Rationale Regenerative endodontics technique outcome depends on microbial elimination because apical repair will not happen in the presence of infected tissues. It is well established that bacteria are essential for the development of pulpal and periapical pathosis. Eradication or control of bacteria may provide optimal treatment outcome. However, elimination of bacteria from infected root canal systems is challenging. Numerous measures have been described to reduce the number of bacteria in the root canal system, including the use of various instrumentation techniques, irrigation regimens and intra-canal medicaments. There is no definitive evidence in the literature that all these measures result in a bacteria-free root canal system.
Therefore additional methods such as the use of intra-canal medicaments are required in order to maximize disinfection of root canal system and kill as many bacteria as possible. Antibiotics have been proposed as intracanal medicament but any single antibiotic is unlikely effective to sterilize diverse flora in root canal infection.
Recently, triple antibiotic mixture (TAP) has been reported for successful disinfection of infected root dentine. This mixture consist of ciprofloxacin (CIP), metronidazole (MET) and minocycline (MINO) which consistently sterilize bacteria of infected dentine and infected pulps . Specifically, MET is a bactericidal imidazole that is highly effective against obligate anaerobic bacteria, CIP is a bactericidal broad-spectrum synthetic quinolone and MINO is a bacteriostatic broad-spectrum tetracycline.
However, as minocycline binds to dentin and causes tooth discoloration, it is recommended to remove minocycline from TAP and use only MET and CIP, or to use modified TAPs containing cefaclor or clindamycin (CLIN). CLIN is a bacteriostatic lincosamide known for its efficacy against a broad spectrum of endodontic bacteria.
In recent years, an innovative strategy has been considered to develop a low-concentration, yet antimicrobially effective and biocompatible polymer-based nanofibrous electrospun scaffolds as a drug delivery system to promote intracanal biofilm eradication . Electrospinning has been considered as a highly effective process to obtain extracellular matrix (ECM) mimicking structures with adequate chemistry and three-dimensional porous architectures Moreover, it has enabled the synthesis of bioactive nanofibrous scaffolds The electrospinning technology has attracted great interest in recent decades, thanks to its capability of easily and effectively processing a huge range of polymeric materials in form of nanofibers. In recent years, the health concerns associated with the systemic side effects of synthetic compounds used in medicine and the emergence of antibiotic resistance of pathogens have driven electrospinning research towards the development of antibiotic loaded nanofibers.
Hypothesis To test the null hypothesis, which is in patients with necrotic immature teeth, will the use of pre-synthesized clindamycin modified triple antibiotic electrospun nanofibers have more profound antimicrobial effect than modified triple antibiotic paste.
Objectives of the present study
- Primary objective To compare the antimicrobial effect of pre-synthesized novel antibiotic loaded nanofibers used in patients with immature necrotic teeth with modified triple antibiotic paste.
- Secondary objective To evaluate the morphology of pre-synthesized antibiotic loaded electrospun nanofibers.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Maxillary or mandibular single-root tooth with:
- Non-vital response of pulp tissue.
- Immature root.
- Asymptomatic patients.
Exclusion Criteria:
- Patients allergic to metronidazole, ciprofloxacin, or clindamycin to avoid allergic reaction in the intervention group.
- Patients who received antibiotics in the past 3 months.
- Vital cases or previously accessed teeth.
- Teeth with unfavorable conditions for rubber-dam application.
- Patients with systemic and immune-compromising disease as they have impaired healing
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: electrospun TAP nanofibers
Revascularization procedure with Electrospun TAP nanofibers as as an intracanal medicament for immature necrotic teeth
|
electrospun TAP loaded nanofibers containing modified triple antibiotic paste of clindamycin , ciprofloxacin and metronidazole by electrospinning process will be placed in the root canals.
The access cavity will be sealed with temporary filling material
|
|
Active Comparator: modified TAP paste
Revascularization procedure with modified TAP paste as an intracanal medicament for immature necrotic teeth
|
modified TAP paste will be prepared by mixing equal proportions of CIP, MET and CLIN then placed inside the root canal, access cavity will be sealed with temporary filling
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
antimicrobial effect
Time Frame: 2-3 weeks
|
number of colony forming units of bacteria after using the intracanal medicaments
|
2-3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
morphology of nanofibers
Time Frame: 1 week
|
surface morphology will be studied under the scanning electron microscope
|
1 week
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Cairo University dentistry
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Necrosis, Pulp
-
Ajman UniversityNot yet recruitingPulp Necrosis | Pulpitis - Irreversible | Pulp Therapy
-
University of FaisalabadNot yet recruiting
-
Ain Shams UniversityNot yet recruiting
-
Fifth Affiliated Hospital of Guangzhou Medical...Not yet recruiting
-
Cairo UniversityNot yet recruitingPulp Necroses
-
CAO Group, Inc.Sao Paulo State University, School of Dentistry at Aracatuba, Sao Paulo,...Completed
-
Cairo UniversityUnknown
-
Faculty of Dental Medicine for GirlsCompleted
-
Nourhan M.AlyAlexandria UniversityTerminatedTooth, Nonvital | Pulp NecrosesEgypt
Clinical Trials on electrospun TAP nanofibers
-
Acera Surgical, Inc.Recruiting
-
Scripps HealthNorth Park PodiatryNot yet recruitingAmputation | Wound; Foot | Wound Complication
-
RenovoDermSimon Tabchi DPM, PA Foot & Ankle Associates; Lindsay Kalan PhD, Kalan Lab,...CompletedDiabetic Foot UlcerUnited States
-
Mansoura UniversityUnknownCholecystitis; GallstoneEgypt
-
Ankara City Hospital BilkentCompletedPostoperative Pain, Acute | Analgesia, Patient-ControlledTurkey
-
Indiana UniversityHalyard HealthCompleted
-
Johns Hopkins UniversityTerminatedDiabetic Retinopathy | Stargardt Disease | Macular Degeneration (Age Related)United States
-
Tianjin First Central HospitalRecruitingPostoperative Pain | Liposomal BupivacaineChina
-
St. Olavs HospitalKarolinska University Hospital; University Hospital of North Norway; Norwegian...WithdrawnCranial Nerve Diseases | Facial Neuralgia | Trigeminal Neuralgia | Hemifacial Spasm
-
Sahiwal medical college sahiwalCompletedBradycardia | Post Operative Analgesia | Opioid Sparing Anaesthesia | Hypotension, Controlled | Stoma Reversal ProcedurePakistan